|
Neoplasia
Citations 111-120 of 4217 total displayed.
|
Past content
(since Jan 1997):
|
Soluble CD22 as a tumor marker for hairy cell leukemia
- Kakushi Matsushita, Inger Margulies, Masanori Onda, Satoshi Nagata, Maryalice Stetler-Stevenson, and Robert J. Kreitman
Blood 2008; 112: 2272-2277.
[Abstract]
[Full text]
[PDF]
Resistance of mature T cells to oncogene transformation
- Sebastian Newrzela, Kerstin Cornils, Zhixiong Li, Christopher Baum, Martijn H. Brugman, Marianne Hartmann, Johann Meyer, Sylvia Hartmann, Martin-Leo Hansmann, Boris Fehse, and Dorothee von Laer
Blood 2008; 112: 2278-2286.
[Abstract]
[Full text]
[PDF]
The hematopoietic stem cell compartment of JAK2V617F-positive myeloproliferative disorders is a reflection of disease heterogeneity
- Chloe James, Frederic Mazurier, Sabrina Dupont, Ronan Chaligne, Isabelle Lamrissi-Garcia, Micheline Tulliez, Eric Lippert, François-Xavier Mahon, Jean-Max Pasquet, Gabriel Etienne, François Delhommeau, Stephane Giraudier, William Vainchenker, and Hubert de Verneuil
Blood 2008; 112: 2429-2438.
[Abstract]
[Full text]
[PDF]
Interruption of the Ras/MEK/ERK signaling cascade enhances Chk1 inhibitor–induced DNA damage in vitro and in vivo in human multiple myeloma cells
- Yun Dai, Shuang Chen, Xin-Yan Pei, Jorge A. Almenara, Lora B. Kramer, Charis A. Venditti, Paul Dent, and Steven Grant
Blood 2008; 112: 2439-2449.
[Abstract]
[Full text]
[PDF]
Targeting MEK/MAPK signal transduction module potentiates ATO-induced apoptosis in multiple myeloma cells through multiple signaling pathways
- Paolo Lunghi, Nicola Giuliani, Laura Mazzera, Guerino Lombardi, Micaela Ricca, Attilio Corradi, Anna Maria Cantoni, Luigi Salvatore, Roberta Riccioni, Antonio Costanzo, Ugo Testa, Massimo Levrero, Vittorio Rizzoli, and Antonio Bonati
Blood 2008; 112: 2450-2462.
[Abstract]
[Full text]
[PDF]
Oncogenic Kit controls neoplastic mast cell growth through a Stat5/PI3-kinase signaling cascade
- Noria Harir, Cédric Boudot, Katrin Friedbichler, Karoline Sonneck, Rudin Kondo, Séverine Martin-Lannerée, Lukas Kenner, Marc Kerenyi, Saliha Yahiaoui, Valérie Gouilleux-Gruart, Jean Gondry, Laurence Bénit, Isabelle Dusanter-Fourt, Kaïss Lassoued, Peter Valent, Richard Moriggl, and Fabrice Gouilleux
Blood 2008; 112: 2463-2473.
[Abstract]
[Full text]
[PDF]
TAT-mediated intracellular delivery of NPM-derived peptide induces apoptosis in leukemic cells and suppresses leukemogenesis in mice
- Yun Zhou, Wei Du, Tara Koretsky, Grover C. Bagby, and Qishen Pang
Blood 2008; 112: 2474-2483.
[Abstract]
[Full text]
[PDF]
Clinical and in vitro resistance to bexarotene in adult T-cell leukemia: loss of RXR- receptor
- Julie H. Lin, Ellen J. Kim, Anand Bansal, John Seykora, Stephen K. Richardson, Xian-Yuan Cha, Sarosh Zafar, Sunita Nasta, Maria Wysocka, Bernice Benoit, Alain H. Rook, and Steven S. Fakharzadeh
Blood 2008; 112: 2484-2488.
[Abstract]
[Full text]
[PDF]
Molecular basis of bortezomib resistance: proteasome subunit β5 (PSMB5) gene mutation and overexpression of PSMB5 protein
- Ruud Oerlemans, Niels E. Franke, Yehuda G. Assaraf, Jacqueline Cloos, Ina van Zantwijk, Celia R. Berkers, George L. Scheffer, Kabir Debipersad, Katharina Vojtekova, Clara Lemos, Joost W. van der Heijden, Bauke Ylstra, Godefridus J. Peters, Gertjan L. Kaspers, Ben A. C. Dijkmans, Rik J. Scheper, and Gerrit Jansen
Blood 2008; 112: 2489-2499.
[Abstract]
[Full text]
[PDF]
FIP1L1/PDGFR synergizes with SCF to induce systemic mastocytosis in a murine model of chronic eosinophilic leukemia/hypereosinophilic syndrome
- Yoshiyuki Yamada, Abel Sanchez-Aguilera, Eric B. Brandt, Melissa McBride, Nabeel J. H. Al-Moamen, Fred D. Finkelman, David A. Williams, Jose A. Cancelas, and Marc E. Rothenberg
Blood 2008; 112: 2500-2507.
[Abstract]
[Full text]
[PDF]
|
|
